TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy

Clinical trial NCT04701021 · COMPLETED

Trial details

NCT number: NCT04701021
Sponsor: Ultimovacs ASA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2021-02-17
Primary completion: 2023-08-16
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.